Medibank Private vs Allianz Which Is Superior?

Medibank Private and Allianz are two major players in the healthcare and insurance industries respectively. Medibank Private is Australia's largest health insurance provider, offering a range of health cover options to its customers. On the other hand, Allianz is a global insurance company with a focus on property and casualty insurance. Both stocks have performed well in recent years but have different growth opportunities and risks associated with them. Investors looking to diversify their portfolio may consider both Medibank Private and Allianz stocks for potential investment opportunities.

Medibank Private or Allianz?

When comparing Medibank Private and Allianz, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Medibank Private and Allianz.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Medibank Private has a dividend yield of 4.45%, while Allianz has a dividend yield of 5.61%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Medibank Private reports a 5-year dividend growth of 2.83% year and a payout ratio of 10946.15%. On the other hand, Allianz reports a 5-year dividend growth of 6.96% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Medibank Private P/E ratio at 2642.01 and Allianz's P/E ratio at 1.23. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Medibank Private P/B ratio is 4.47 while Allianz's P/B ratio is 0.22.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Medibank Private has seen a 5-year revenue growth of 0.13%, while Allianz's is 12.08%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Medibank Private's ROE at 0.17% and Allianz's ROE at 16.99%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are A$3.69 for Medibank Private and $30.71 for Allianz. Over the past year, Medibank Private's prices ranged from A$3.40 to A$4.01, with a yearly change of 17.94%. Allianz's prices fluctuated between $23.42 and $33.19, with a yearly change of 41.72%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.